Saturday, October 3, 2026

EUR/GBP Bearish By 1% In The Last 21 Sessions

EUR/GBP Bearish By 1% In The Last 21 Sessions

(VIANEWS) - EUR/GBP (EURGBP) has been up by 1.55% for the last 21 sessions. At 13:09 EST on Friday, 19 May, EUR/GBP (EURGBP) is $0.87.

EUR/GBP's yearly highs and lows, it's 4.065% up from its 52-week low and 6.031% down from its 52-week high.

Volatility

EUR/GBP's last week, last month's, and last quarter's current intraday variation average was a negative 0.10%, a negative 0.14%, and a positive 0.27%, respectively.

EUR/GBP's highest amplitude of average volatility was 0.20% (last week), 0.26% (last month), and 0.27% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/GBP's Forex is considered to be overbought (>=80).

News about

  • Usd/jpy prods five-day uptrend above 136.00 on upbeat Japan gdp, receding US default fears. According to FXStreet on Wednesday, 17 May, "Unless dropping back below the early-month top surrounding 135.50, the USD/JPY remains capable of marking another attempt in crossing the 200-DMA hurdle of around 137.10.", "Apart from the Japanese GDP, recent hopes of more investment by private firms in Japan also weigh on the USD/JPY pair. "
  • Usd/jpy trades with modest losses around mid-137.00s, downside seems cushioned. According to FXStreet on Thursday, 18 May, "Traders will further take cues from speeches by influential FOMC members, which, along with the US bond yields, will drive the USD demand and provide some impetus to the USD/JPY pair. ", "That said, a combination of factors continues to act as a tailwind for the USD/JPY pair and limit the downside, warranting some caution for aggressive bearish traders."
  • Usd/jpy price analysis: climbs above 136.50 despite upbeat Japan’s GDP. According to FXStreet on Wednesday, 17 May, "The USD/JPY pair has resumed its upside journey after a marginal correction below 136.50 in the Asian session. ", "This would drag the USD/JPY pair towards May 11 high at 134.84 followed by May 11 low at 133.74."
  • Usd/jpy looks to build on bullish move beyond 137.00, 200 DMA on stronger USD. According to FXStreet on Wednesday, 17 May, "Nevertheless, the aforementioned fundamental backdrop suggests that the path of least resistance for the USD/JPY pair is to the upside. ", "The US Dollar (USD) continues to draw support from the recent hawkish remarks by several Federal Reserve (Fed) officials and climbs to a nearly two-month high, which, in turn, is seen as a key factor acting as a tailwind for the USD/JPY pair. "

More news about EUR/GBP (EURGBP).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com
EUR/GBP Bearish By 1% In The Last 21 Sessions | Via News